发明申请
![1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS](/docs/US/2023-04-27/US20230130516A1/abs.jpg.600x600.jpg)
- 专利标题： 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
-
申请号： US17792878申请日： 2021-01-26
-
公开(公告)号： US20230130516A1公开(公告)日： 2023-04-27
- 发明人: Qian ZHANG , Sanjeev GANGWAR , Ashvinikumar V. GAVAI , Qiang CONG , Yam B. POUDEL , Liqi HE , Prasanna SIVAPRAKASAM , Christine M. TARBY
- 申请人： BRISTOL-MYERS SQUIBB COMPANY
- 申请人地址： US NJ Princeton
- 专利权人： BRISTOL-MYERS SQUIBB COMPANY
- 当前专利权人： BRISTOL-MYERS SQUIBB COMPANY
- 当前专利权人地址： US NJ Princeton
- 国际申请： PCT/US2021/014979 WO 20210126
- 主分类号： A61K31/519
- IPC分类号： A61K31/519 ; C07D487/04 ; C07D519/00 ; A61K31/5377 ; A61K39/395
![1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS](/abs-image/US/2023/04/27/US20230130516A1/abs.jpg.150x150.jpg)
摘要：
Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.
信息查询
IPC分类:
